NCT05625932 2025-08-22
PROTINCOL
Galician Research Group on Digestive Tumors
Phase 3 Completed
Clinical Trials
15 trialsNCT01370278 2023-08-25
Clearance Of Mucus In Stents (COMIS)
M.D. Anderson Cancer Center
Phase NA Completed
NCT04072068 2023-05-30
EDOI
Gruppo Oncologico Italiano di Ricerca Clinica
Phase 4 Completed
NCT00740116 2022-03-15
Tranexamic Acid in Surgery of Advanced Ovarian Cancer
University Hospital, Linkoeping
Phase 4 Completed
NCT04616846 2022-03-09
NEOTHROCOVID
Centre Antoine Lacassagne
Phase NA Completed
NCT02444572 2021-07-29
ENOXACARE
Les Laboratoires des Médicaments Stériles
Phase 4 Completed
NCT01696760 2018-12-05
Aspirin and Compression Devices for VTE Prophylaxis in Orthopaedic Oncology
Ohio State University Comprehensive Cancer Center
Phase NA Completed
NCT00381888 2017-12-28
Fondaparinux in Preventing Blood Clots in Patients Undergoing Surgery for Gynecologic Cancer
Masonic Cancer Center, University of Minnesota
Phase 2 Completed
NCT01741506 2015-06-23
COPPVATS
Aarhus University Hospital
Phase 4 Completed
NCT01945879 2013-09-19
Pilot Safety Trial of Chemotherapy and Use of Heparin in Patients With Pancreatic Cancer
CONKO-Studiengruppe
Phase 1/2 Completed
NCT00462852 2013-08-12
Gemcitabine With or Without Dalteparin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT00024297 2013-08-07
Warfarin in Preventing Blood Clots in Cancer Patients With Central Venous Catheters
National Cancer Institute (NCI)
Phase NA Completed
NCT00020189 2013-06-19
Flavopiridol in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT00014352 2013-01-16
Combination Chemotherapy Plus Warfarin in Treating Patients With Prostate Cancer
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT00951574 2012-02-01
Prevention of Venous and Arterial Thromboembolism, in Cancer Patients Undergoing Chemotherapy, With a Low Molecular Weight Heparin (Nadroparin Calcium)
Italfarmaco
Phase 3 Completed